miR-26 family and its target genes in tumorigenesis and development
- 1 January 2021
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 157, 103124
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Overexpression of miR-26a-2 in human liposarcoma is correlated with poor patient survivalOncogenesis, 2013
- Development of a miR-26 Companion Diagnostic Test for Adjuvant Interferon-alpha Therapy in Hepatocellular CarcinomaInternational Journal of Biological Sciences, 2013
- Microarray analysis of microRNA expression in cutaneous squamous cell carcinomaJournal of Dermatological Science, 2012
- High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancerBreast Cancer Research and Treatment, 2011
- Tumor-specific Expression of MicroRNA-26a Suppresses Human Hepatocellular Carcinoma Growth via Cyclin-dependent and -independent PathwaysMolecular Therapy, 2011
- Overexpression of TRIB2 in human lung cancers contributes to tumorigenesis through downregulation of C/EBPαOncogene, 2011
- MicroRNA Expression, Survival, and Response to Interferon in Liver CancerNew England Journal of Medicine, 2009
- Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer ModelCell, 2009
- Widespread microRNA repression by Myc contributes to tumorigenesisNature Genetics, 2007
- A Mammalian microRNA Expression Atlas Based on Small RNA Library SequencingCell, 2007